5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.39▼ | 1.39▼ | 1.41▼ | 1.40▼ | 1.54▼ |
MA10 | 1.41▼ | 1.41▼ | 1.43▼ | 1.48▼ | 1.74▼ |
MA20 | 1.45▼ | 1.45▼ | 1.46▼ | 1.56▼ | 2.35▼ |
MA50 | 1.50▼ | 1.52▼ | 1.53▼ | 1.80▼ | 5.83▼ |
MA100 | 1.56▼ | 1.59▼ | 1.64▼ | 2.40▼ | 16.39▼ |
MA200 | 1.75▼ | 1.81▼ | 1.95▼ | 4.01▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.005▼ | -0.005▼ | -0.006▼ | 0.281▲ |
RSI | 35.682▼ | 36.264▼ | 35.873▼ | 29.427▼ | 28.273▼ |
STOCH | 8.120▼ | 17.542▼ | 23.077 | 6.579▼ | 6.194▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
CCI | -74.171 | -78.810 | -98.432 | -157.112▼ | -111.518▼ |
Wednesday, August 06, 2025 08:29 AM
Battery manufacturer EnerSys (NYSE:ENS) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $893 million. On the other hand, next quarter ...
|
Sunday, June 08, 2025 05:00 PM
Charles Cherington, a 10% owner of $ERNA, bought 21,241,163 shares of the company on 06-09-2025 for an estimated $2,221,825. This trade was reported by Quiver ...
|
Wednesday, May 28, 2025 05:43 AM
Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
29/08/25 | 1.3873 | 1.3999 | 1.33 | 1.33 | 37,888 |
28/08/25 | 1.43 | 1.47 | 1.3701 | 1.38 | 58,097 |
27/08/25 | 1.51 | 1.5299 | 1.3701 | 1.39 | 96,183 |
26/08/25 | 1.5589 | 1.5589 | 1.48 | 1.49 | 12,771 |
25/08/25 | 1.48 | 1.5273 | 1.433 | 1.433 | 59,528 |
22/08/25 | 1.50 | 1.56 | 1.48 | 1.50 | 73,700 |
21/08/25 | 1.55 | 1.59 | 1.51 | 1.52 | 57,106 |
20/08/25 | 1.57 | 1.62 | 1.52 | 1.55 | 9,800 |
19/08/25 | 1.58 | 1.62 | 1.55 | 1.55 | 28,100 |
18/08/25 | 1.59 | 1.70 | 1.57 | 1.61 | 36,200 |
|
|
||||
|
|
||||
|
|